CYAN - サイアノテック (Cyanotech Corporation) サイアノテック

 CYANのチャート


 CYANの企業情報

symbol CYAN
会社名 Cyanotech Corp. (サイアノテック)
分野(sector) Consumer Durables   耐久消費財
産業(industry) Specialty Chemicals  
業種 医薬品   一般消費財(Consumer Products)
概要 事業概要 シアノテク(Cyanotech Corporation)は微細藻類から得られる天然物の生産を行う会社である。同社の製品は「Hawaiian Spirulina Pacifica」及び「Hawaiian BioAstin」を含む。「Hawaiian Spirulina Pacifica」は抗酸化カロチノイドの源として余分なエネルギー、強化された免疫システム及び心血管有益に使用される栄養豊富な補助食品である。「Hawaiian BioAstin」は身体の自然炎症反応への支援・維持または皮膚の強化、及び目・関節の健康を支援することが証明されている天然アスタキサンチンと食物抗酸化剤である。同社は製品が人間の栄養補助食品及び機能性食品成分としての適用範囲を拡大した。同社は大規模なベースと2種類の微細藻類を養殖し、スピルリナ製品および天然アスタキサンチン製品という同社の2つの主要製品ラインを生成する。   サイアノテックは米国の自然食品会社。微細藻類による自然健康・栄養製品の生産に従事。スピルリナ製品と天然アスタキサンチン製品の2種類の微細藻類の栽培を手掛け、エネルギ―、免疫、心血管系栄養補助食品のハワイアンスピルリナパシフィカを提供。また皮膚の強化、目・関節の健康サポ―ト向けにハワイアンバイオアスティン天然アスタキサンチンを提供する。   Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. Its products include BioAstin natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health; and Spirulina Pacifica, a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
本社所在地 73-4460 Queen Kaahumanu Highway Suite 102 Kailua-Kona HI 96740 USA
代表者氏名 Michael A. Davis マイケル・A・デイビス
代表者役職名 Independent Chairman of the Board
電話番号 +1 808-326-1353
設立年月日 30621
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 118人
url www.cyanotech.com
nasdaq_url https://www.nasdaq.com/symbol/cyan
adr_tso
EBITDA EBITDA(百万ドル) 1.50000
終値(lastsale) 3.4206
時価総額(marketcap) 19801466.8722
時価総額 時価総額(百万ドル) 18.98755
売上高 売上高(百万ドル) 32.45100
企業価値(EV) 企業価値(EV)(百万ドル) 25.59855
当期純利益 当期純利益(百万ドル) 0.44900
決算概要 決算概要 BRIEF: For the three months ended 30 June 2018 CYANOTECH CORP revenues decreased 19% to $7.1M. Net loss totaled $1.3M vs. income of $501K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Research and Development increase of 46% to $208K (expense) Interest expense increase of 20% to $130K (expense) General/Adminstration increase of 1% to $1.4M (expense).

 CYANのテクニカル分析


 CYANのニュース

   Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020  2020/02/11 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
   [PDF] Spirulina Market Analysis | Top players GNC Holding, Now Health Group, Prolgae, Algatec,Cyanotech, DIC Corporation  2020/01/31 10:13:04 EIN News
The global spirulina market generated $346 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
   Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020  2019/11/12 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020. Net sales increase 10.6% to $7,690,000.
   Cyanotech Corporation (CYAN) CEO Mawae Morton on Q3 2019 Results - Earnings Call Transcript  2019/02/16 12:51:12 Seeking Alpha
Cyanotech Corporation (NASDAQ:CYAN) Q3 2019 Earnings Conference Call February 15, 2019, 08:00 PM ET Company Participants Mawae Morton - CEO Brian Orlopp - CFO C
   Cyanotech reports Q3 results  2019/02/13 14:07:18 Seeking Alpha
   Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020  2020/02/11 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
   [PDF] Spirulina Market Analysis | Top players GNC Holding, Now Health Group, Prolgae, Algatec,Cyanotech, DIC Corporation  2020/01/31 10:13:04 EIN News
The global spirulina market generated $346 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
   Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020  2019/11/12 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020. Net sales increase 10.6% to $7,690,000.
   Cyanotech Corporation (CYAN) CEO Mawae Morton on Q3 2019 Results - Earnings Call Transcript  2019/02/16 12:51:12 Seeking Alpha
Cyanotech Corporation (NASDAQ:CYAN) Q3 2019 Earnings Conference Call February 15, 2019, 08:00 PM ET Company Participants Mawae Morton - CEO Brian Orlopp - CFO C
   Cyanotech reports Q3 results  2019/02/13 14:07:18 Seeking Alpha
   Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020  2020/02/11 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
   [PDF] Spirulina Market Analysis | Top players GNC Holding, Now Health Group, Prolgae, Algatec,Cyanotech, DIC Corporation  2020/01/31 10:13:04 EIN News
The global spirulina market generated $346 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
   Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020  2019/11/12 13:00:00 Business Wire
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020. Net sales increase 10.6% to $7,690,000.
   Cyanotech Corporation (CYAN) CEO Mawae Morton on Q3 2019 Results - Earnings Call Transcript  2019/02/16 12:51:12 Seeking Alpha
Cyanotech Corporation (NASDAQ:CYAN) Q3 2019 Earnings Conference Call February 15, 2019, 08:00 PM ET Company Participants Mawae Morton - CEO Brian Orlopp - CFO C
   Cyanotech reports Q3 results  2019/02/13 14:07:18 Seeking Alpha

 関連キーワード  (医薬品 米国株 サイアノテック CYAN Cyanotech Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)